Atlas Trials

Clinical Study to Assess the Pharmacokinetics, Safety, and Tolerability of ACT-129968 in Healthy Subjects

Clinical trial NCT01877629 · COMPLETED

Trial details

NCT number
NCT01877629
Sponsor
Idorsia Pharmaceuticals Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Subjects
Start date
2011-07-01
Primary completion
2011-07-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.